Are you Dr. Pulte?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 59 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1015 Chestnut St
Suite 1321
Philadelphia, PA 19107Phone+1 215-955-4730Fax+1 215-503-9188
Summary
- Dr. Elizabeth Pulte, MD is an oncologist in Philadelphia, Pennsylvania. She is currently licensed to practice medicine in Pennsylvania, New Jersey, and New York. She is affiliated with Thomas Jefferson University Hospital and is an Assistant Professor at Jefferson Medical College-Thos Jefferson Univ.
Education & Training
- NYU Grossman School of MedicineFellowship, Hematology and Medical Oncology, 2000 - 2002
- NYU Grossman School of MedicineFellowship, Hematology and Medical Oncology, 1999 - 2000
- University of Iowa Hospitals and ClinicsResidency, Internal Medicine, 1997 - 1998
- University of Iowa Hospitals and ClinicsResidency, Internal Medicine, 1994 - 1996
- The University of Texas Health Science Center at San AntonioClass of 1994
Certifications & Licensure
- NY State Medical License 1999 - 2027
- PA State Medical License 2011 - 2022
- NJ State Medical License 2008 - 2021
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012-2013
Clinical Trials
- Treatment of Sickle Cell Anemia With Stem Cell Transplant Start of enrollment: 2009 Sep 01
Publications & Presentations
PubMed
- 3 citationsComplete remission with partial hematological recovery as a palliative endpoint for treatment of acute myeloid leukemia.Robert Q Le, Donna Przepiorka, Haiyan Chen, Yuan Li Shen, E Dianne Pulte
Blood. 2024-07-11 - 13 citationsResponse Rate, Event-Free Survival, and Overall Survival in Newly Diagnosed Acute Myeloid Leukemia: US Food and Drug Administration Trial-Level and Patient-Level Analy...Kelly J Norsworthy, Xin Gao, Chia-Wen Ko, E Dianne Pulte, Jiaxi Zhou
Journal of Clinical Oncology. 2022-03-10 - 5 citationsFDA Approval Summary: Revised Indication and Dosing Regimen for Ponatinib Based on the Results of the OPTIC Trial.E Dianne Pulte, Haiyan Chen, Lauren S L Price, Ramadevi Gudi, Hongshan Li
The Oncologist. 2022-03-04